The ACROPOLI clinical trial is being launched. It is a pioneering, nationwide research study that aims to assess the efficacy of immunotherapy in 29 different...
In a study published in the Journal of Clinical Oncology, researchers from the Hospital Clínic-IDIBAPS-UB and SOLTI showed the predictive capacity of the...
Dr. Aleix Prat, head of the Service of Medical Oncology at Hospital Clínic, head of the Translational genomics and targeted therapies in solid tumours IDIBAPS...
The University of Barcelona, Hospital Clínic and the pharmaceutical company AstraZeneca created the UB-Hospital Clínic Chair on Lung Cancer AstraZeneca....
Reserachers of Hospital Clínic-IDIBAPS participate in EuCanImage, a project from the Horizon 2020 program that will build a federated and scalable cancer...
Reveal Genomics’ first goal will be to develop diagnostic tools based on complex genomic data for patients with advanced breast cancer.
In recent years, one of the strategies developed in the field of haematology is the modification of the patient’s immune system, also known as ‘immunotherapy’....
Today the results of the phase 2 CORALLEEN clinical trial, promoted by the international academic group SOLTI, have been presented. The study, published...
Hospital Clínic of Barcelona will apply the leading comprehensive liquid biopsy test currently available for patients with advanced cancer, in the context...
The latest advance in the field of immune therapies against cancer are the active and targeted CAR therapies. This treatment consists of obtaining the...
